VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2016 | Global differences in cancer drug prices: a comparative analysis

Daniel Goldstein • 3 Jun 2016
ASCO 2016
Breast Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecological Cancer Lung Cancer Skin Cancer

Press brief by Daniel Goldstein, MD of the Rabin Medical Center, Petah Tikva, Israel, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

More from Daniel Goldstein

0:52
Cancer care: the need for a cost-effective approach
Daniel Goldstein • 2 Jun 2017
0:51
Are physicians wasting healthcare resources by over-prescribing drugs?
Daniel Goldstein • 2 Jun 2017
2:09
Is the current dose of pembrolizumab approved for treating lung cancer too high?
Daniel Goldstein • 2 Jun 2017
2:15
Personalized dosing of pembrolizumab has the potential to save $0.8 billion per year
Daniel Goldstein

Related Videos

5:46
MAHOGANY: margetuximab in gastric cancer
Daniel V. Catenacci • 20 Jan 2021
3:23
TAGS: impact of prior therapies on outcomes with trifluridine/tipiracil
Kohei Shitara • 20 Jan 2021
3:15
Health-related quality of life in young CRC survivors
Afsaneh Barzi • 18 Jan 2021
1:31
Disparities in access to screening and variation of targets in different groups
Afsaneh Barzi • 18 Jan 2021
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals